DK0854873T3 - Galathanminderivater og fremgangsmåde til deres fremstilling - Google Patents

Galathanminderivater og fremgangsmåde til deres fremstilling

Info

Publication number
DK0854873T3
DK0854873T3 DK96931169T DK96931169T DK0854873T3 DK 0854873 T3 DK0854873 T3 DK 0854873T3 DK 96931169 T DK96931169 T DK 96931169T DK 96931169 T DK96931169 T DK 96931169T DK 0854873 T3 DK0854873 T3 DK 0854873T3
Authority
DK
Denmark
Prior art keywords
pct
hydrogen
galatine
miner
derivatives
Prior art date
Application number
DK96931169T
Other languages
English (en)
Inventor
David Peter
Fraser Neil
Andrew David
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0854873T3 publication Critical patent/DK0854873T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK96931169T 1995-09-21 1996-09-23 Galathanminderivater og fremgangsmåde til deres fremstilling DK0854873T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9519267.0A GB9519267D0 (en) 1995-09-21 1995-09-21 Preparation of alkaloids
PCT/GB1996/002334 WO1997011077A1 (en) 1995-09-21 1996-09-23 Galanthamine derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
DK0854873T3 true DK0854873T3 (da) 2002-07-01

Family

ID=10781038

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96931169T DK0854873T3 (da) 1995-09-21 1996-09-23 Galathanminderivater og fremgangsmåde til deres fremstilling

Country Status (13)

Country Link
US (1) US6093815A (da)
EP (1) EP0854873B1 (da)
AT (1) ATE214070T1 (da)
AU (1) AU714711B2 (da)
CA (1) CA2230826C (da)
CY (1) CY2301B1 (da)
DE (1) DE69619685T2 (da)
DK (1) DK0854873T3 (da)
ES (1) ES2173316T3 (da)
GB (1) GB9519267D0 (da)
PT (1) PT854873E (da)
WO (1) WO1997011077A1 (da)
ZA (1) ZA968028B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1891954A3 (en) 1998-09-30 2009-01-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
JP2003136077A (ja) * 2001-10-31 2003-05-13 Nec Corp 半導体製造に用いる洗浄水又は浸漬水の製造装置
CA2552114A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
WO2005065661A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galanthamine
PL1895994T3 (pl) * 2005-05-13 2011-02-28 Alza Corp Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
AT504663B1 (de) * 2007-02-22 2008-07-15 Sanochemia Pharmazeutika Ag Verfahren zum herstellen von hochreinen 4a,5,9,10,11,12,-hexahydro-6h-benzofuro(3a,3,2- f)(2) benzazepinen sowie dessen derivaten
ATE540955T1 (de) * 2007-06-18 2012-01-15 Aurobindo Pharma Ltd Herstellungsprozess für galantaminhydrobromid
AT507039A1 (de) 2008-06-26 2010-01-15 Sanochemia Pharmazeutika Ag Verfahren zum herstellen von hochreinen benzazepinderivaten
CN106977412B (zh) * 2017-05-15 2019-08-02 张家港威胜生物医药有限公司 一种加兰他敏关键中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE411026T1 (de) * 1987-05-04 2008-10-15 Bonnie Davis Mittel zur behandlung der alzheimer-krankheit
BR9509406A (pt) * 1994-10-21 1998-11-03 Waldheim Pharmazeutica Ges M B Processo para a preparação de 4a,5,9,10,11,12,-hedaxidro-6h-benzofuro(3a,3,2,-ef) [2] benzazepina
AT401058B (de) * 1994-10-21 1996-06-25 Waldheim Pharmazeutika Gmbh Verfahren zum herstellen von derivaten des 4a,5, 9,10,11,12,-hexahydro-6h-benzofuro(3a,-3,2-ef) (2)benzazepins

Also Published As

Publication number Publication date
PT854873E (pt) 2002-08-30
US6093815A (en) 2000-07-25
AU714711B2 (en) 2000-01-06
ES2173316T3 (es) 2002-10-16
WO1997011077A1 (en) 1997-03-27
GB9519267D0 (en) 1995-11-22
CY2301B1 (en) 2003-07-04
ATE214070T1 (de) 2002-03-15
CA2230826A1 (en) 1997-03-27
EP0854873A1 (en) 1998-07-29
DE69619685D1 (de) 2002-04-11
CA2230826C (en) 2008-09-02
ZA968028B (en) 1997-09-23
AU6996496A (en) 1997-04-09
DE69619685T2 (de) 2002-10-17
EP0854873B1 (en) 2002-03-06

Similar Documents

Publication Publication Date Title
DE69711391T2 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
DK0854873T3 (da) Galathanminderivater og fremgangsmåde til deres fremstilling
AU3415599A (en) Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
ES2061966T3 (es) Mejoras introducidas en la sintesis de derivados 6-metilenicos de androsta-1,4-dieno-3,17-diona.
DE69214784T2 (de) Verfahren zur herstellung von cephalosporinzwischenverbindungen
EP0994106A4 (en) METHOD FOR PRODUCING CARBAMOYL-SUBSTITUTED IMIDAZOLE DERIVATIVES
IS2274B (is) Aðferð til að búa til kamptóþesín afleiður
NO864665D0 (no) Nye basisk substituerte pyridinforbindelser, fremgangsmaate til deres fremstilling, legemiddel inneholdende dem, og deres anvendelse.
ATE53212T1 (de) Norfloxacin-zwischenverbindung.
ATE30718T1 (de) Herstellung von 1-benzyl azetidin-3-ol und von dem entsprechenden halid acid.
PL312229A1 (en) Derivatives of abeo-ergoline as 5ht1a ligands
DE3567205D1 (en) Method for the preparation of amino-triazinone derivatives
NO983956L (no) Nye 1(2H)-kinolin-karboksylsyrederivater, fremgangsmÕte for fremstilling av disse og anvendelse derav for syntese og substanser med antibiotiske egenskaper
BG100704A (en) New piperazine derivatives and methods for their preparation as well as of the compounds containing them
MX9700662A (es) Procedimiento para la preparacion estereoselectivade un enantiomero de alcohol hetero-biciclico.
DK1056769T3 (da) 15-methyl-cyclopropanosteroider og fremgangsmåde til deres fremstilling